- Home
- NMCO vs LAB Comparison
NMCO vs LAB Comparison
Compare NMCO & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMCO
- LAB
- Stock Information
- Founded
- NMCO 2019
- LAB 1999
- Country
- NMCO United States
- LAB United States
- Employees
- NMCO N/A
- LAB N/A
- Industry
- NMCO Finance/Investors Services
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- NMCO Finance
- LAB Industrials
- Exchange
- NMCO Nasdaq
- LAB Nasdaq
- Market Cap
- NMCO 599.0M
- LAB 504.2M
- IPO Year
- NMCO N/A
- LAB 2011
- Fundamental
- Price
- NMCO $10.93
- LAB $1.14
- Analyst Decision
- NMCO
- LAB Hold
- Analyst Count
- NMCO 0
- LAB 2
- Target Price
- NMCO N/A
- LAB $1.35
- AVG Volume (30 Days)
- NMCO 207.6K
- LAB 1.6M
- Earning Date
- NMCO 01-01-0001
- LAB 11-04-2025
- Dividend Yield
- NMCO 5.43%
- LAB N/A
- EPS Growth
- NMCO N/A
- LAB N/A
- EPS
- NMCO N/A
- LAB N/A
- Revenue
- NMCO N/A
- LAB $169,737,000.00
- Revenue This Year
- NMCO N/A
- LAB N/A
- Revenue Next Year
- NMCO N/A
- LAB N/A
- P/E Ratio
- NMCO N/A
- LAB N/A
- Revenue Growth
- NMCO N/A
- LAB 44.70
- 52 Week Low
- NMCO $8.52
- LAB $0.92
- 52 Week High
- NMCO $11.64
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- NMCO 58.49
- LAB 39.05
- Support Level
- NMCO $10.67
- LAB $1.12
- Resistance Level
- NMCO $10.82
- LAB $1.25
- Average True Range (ATR)
- NMCO 0.12
- LAB 0.08
- MACD
- NMCO 0.01
- LAB -0.02
- Stochastic Oscillator
- NMCO 86.53
- LAB 11.76
About NMCO Nuveen Municipal Credit Opportunities Fund
Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.